Enhanced Validation

Anti-ACE2 Antibody

angiotensin I converting enzyme 2
Recommended Applications
Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.
Product Description
Polyclonal Antibody against Human ACE2
Product Number
Unit Size
100 µl
Lot dependent
>10 in Stock
Ready to Ship
Target Protein
angiotensin I converting enzyme 2
Target Gene
Antigen Sequence
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
Verified Species Reactivity
Interspecies Information

Highest antigen sequence identity to the following orthologs:

Mouse ENSMUSG00000015405 (74%)

Rat ENSRNOG00000031665 (46%)

40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Purification Method
Affinity purified using the PrEST antigen as affinity ligand
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Unit Size
100 µl
Current Lot
Produced on demand. Contact support@atlasantibodies.com for more information.
Product Data Sheet
Immunohistochemistry (IHC)

Recommended conditions:

Dilution: 1:500 - 1:1000

Retrieval method: HIER pH6

Western Blot (WB)

Recommended conditions:

Working concentration: 0.04-0.4 µg/ml

Immunohistochemistry (IHC)

Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.

Western Blot (WB)

Validated in Western blot using relevant lysates (see Western blot application images above)

Protein Name
angiotensin I converting enzyme 2
Gene Name
UniProt ID
Gene (Ensembl)
Entrez Gene ID
Normally shipped at ambient temperature
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Human Protein Atlas

This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.

All characterization data for ENSG00000130234 on the Human Protein Atlas

Alawi LF, Emberesh SE, Owuor BA, Chodavarapu H, Fadnavis R, El‐Amouri SS, Elased KM

Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice

Physiol Rep , 2020 Feb 5; 8(3):e14364. Epub 2020 Feb 5

PubMed ID: 32026607 DOI: 10.14814/phy2.14364

Kato BS, Nicholson G, Neiman M, Rantalainen M, Holmes CC, Barrett A, Uhlén M, Nilsson P, Spector TD, Schwenk JM

Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model

Proteome Sci , 2011 Nov 17; 9:73. Epub 2011 Nov 17

PubMed ID: 22093360 DOI: 10.1186/1477-5956-9-73

Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR

Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.

Gastroenterology , 2010 Jul; 139(1):213-25.e3. Epub 2010 Apr 13

PubMed ID: 20398667 DOI: 10.1053/j.gastro.2010.04.008

Did we miss your publication?

Have you published using HPA000288? Please let us know and we will be happy to include your reference on this page.

Read more

The protein expression profile of ACE2 in human tissues

Contribution from The Human Protein Atlas (proteinatlas.org) — April 21, 2020

Feria Hikmet*, Loren Méar*, Mathias Uhlén**, Cecilia Lindskog*

*Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden
**Science for Life Laboratory, School of engineering Sciences in Chemistry, Biotechnology and health, KTH - Royal Institute of Technology, Stockholm, Sweden and Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden 

The international spread of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) poses a global challenge on both healthcare and society. A multitude of research efforts worldwide aim at characterizing the cellular factors involved in viral transmission in order to reveal therapeutic targets. For a full understanding of the susceptibility for SARS-CoV-2 infection, the cell type-specific expression of the host cell surface receptor is necessary. The key protein suggested to be involved in host cell entry is Angiotensin I converting enzyme 2 (ACE2), and its expression has been reported in various human organs, in some cases with inconsistent or contradictory results. Here, we aim to verify a reliable expression profile of ACE2 in all major human tissues and cell types. Based on stringently validated immunohistochemical analysis and high-throughput mRNA sequencing from several datasets, we found that ACE2 expression is mainly localized to microvilli of the intestinal tract and renal proximal tubules, gallbladder epithelium, testicular Sertoli cells and Leydig cells, glandular cells of seminal vesicle and cardiomyocytes. The expression in several other previously reported locations, including alveolar type II (AT2) cells, could not be confirmed. Furthermore, ACE2 expression was absent in the AT2 lung carcinoma cell line A549, often used as a model for viral replication studies. Our analysis suggests that the expression of ACE2 in the human respiratory system appears to be limited, and the expression of the receptor in lung or respiratory epithelia on the protein level is yet to be confirmed. This raises questions regarding the role of ACE2 for infection of human lungs and highlights the need to further explore the route of transmission during SARS-CoV-2 infection.


Cell type-specific localization of ACE2 in human tissues based on immunohistochemistry.

Representative images of 18 tissue types and histological structures stained with immunohistochemistry using the polyclonal rabbit antibody HPA000288 (Atlas Antibodies AB), targeting human ACE2 protein (brown), and counterstained with hematoxylin (blue). Highest ACE2 expression was observed in microvilli of the intestinal tract and renal proximal tubules, in membranes of gallbladder epithelium, testicular Sertoli cells and Leydig cells, a subset of glandular cells in seminal vesicle (arrowheads), and in cytoplasm cardiomyocytes. Note that ACE2 protein expression was not detected in the lower parts of the mucosal intestinal layer. No protein expression was observed in lung, bronchus, nasopharynx, esophagus, stomach, endometrium, smooth muscle tissue (visualized in muscle layer of small intestine), spleen, cerebral cortex, adipose tissue or different structures of the skin. Protein expression was neither detected in endothelial cells, here shown in cerebral cortex (arrow), nor in fibroblasts, here sown in dermis layer of skin (arrows). For details, see https://www.proteinatlas.org/ENSG00000130234-ACE2/tissue.

Full text: 
bioRxiv preprint


Join the Explorer Program

Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers 50% of the product price as a refund, or 50% discount on your next vial purchase.

Read more

Corresponding Antigens


Our customer support and expert scientific support teams are here to help you succeed in your research.

Get in touch